Company profile
InspireMD, Inc.
NASDAQ: NSPR · Healthcare · Medical - Devices
PublicHQ Miami, CIK 0001433607Reports USD
#647 of 1,418 Healthcare companies by revenue71st-percentile growth
EA Score
60CFH 44DQ 80GM 69SS 62
v0.1 · 65/100 weight · provisional
↑ disclosure history, balance-sheet leverage · ↓ operating margin, net margin
Methodology →Revenue TTM
$10.8M
Rev growth YoY (TTM)
+54.4%
Net income (FY)
-$48.8M
Employees
127
as of 2026-07-19
Market cap
$33.7M
as of 2026-07-19
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$9.0M$9.0M2025
Net income-$48.8M-$48.8M2025
Operating income-$49.6M-$49.6M2025
Total assets$69.4M$69.4M2025
Liabilities$14.2M$14.2M2025
Equity$55.2M$55.2M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is InspireMD, Inc.’s revenue?
InspireMD, Inc. booked $9.0M in FY2025 revenue, growing 28% year over year — faster than most Healthcare companies we track, at a -543.3% net margin.
Peers · Healthcare
Hempfusion Wellness Inc.——CareView Communications, Inc.52DBioAge Labs Inc.51DMilestone Scientific Inc.41DHerbal Dispatch Inc.52DMJardin Group, Inc.——Key facts
CEOMarvin L. Slosman
SectorHealthcare
IndustryMedical - Devices
HeadquartersMiami, null
ExchangeNASDAQ: NSPR
Employees127
IPO date2011-04-12
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.